Key Stocks to Watch: TCS, Tata Elxsi, IREDA, Mazagon Dock, Zydus Lifesciences, and More Announce Major Updates

Here are the key stocks to keep an eye on today:

TCS (Tata Consultancy Services) reported a consolidated net profit of ₹11,909 crore in Q2FY25, a 5% increase from ₹11,342 crore last year. The company’s revenue rose by 7.7% to ₹64,259 crore, compared to ₹59,692 crore in Q2FY24. In constant currency, revenue grew 5.5%. TCS recorded an operating margin of 24.1% and a net margin of 18.5%, with a slight 0.2% drop in the operating margin compared to last year.

ADVERTISEMENT

Be part of our community by downloading and registering on the Angel One app. Your support helps us keep delivering quality content.

Tata Elxsi beat market expectations, with a 14.7% rise in profit to ₹229 crore for the second quarter, driven by strong demand in the transportation sector. Revenue grew by 8.3% to ₹955 crore, in line with analysts’ predictions.

IREDA (Indian Renewable Energy Development Agency) posted a net profit of ₹388 crore for Q2FY25, a 36% increase compared to ₹285 crore in the same period last year. The profit was also slightly higher than the ₹383 crore recorded in the previous quarter. Total income grew 38.5% to ₹1,630 crore, compared to ₹1,177 crore last year and ₹1,510 crore in the June quarter.

Mazagon Dock Shipbuilders secured a ₹121.7 crore contract from the Maharashtra State Power Generation Company (MAHAGENCO) for an AI-based security project.

Bandhan Bank announced that Partha Pratim Sengupta has been appointed as its new MD & CEO by the Reserve Bank of India. He will begin his three-year term by November 10.

Anand Rathi Wealth reported a 32.4% year-on-year rise in profit to ₹76.1 crore for Q2FY25, while revenue increased by 32.8% to ₹242.5 crore.

Den Networks saw a 14% profit increase, reaching ₹52 crore for Q2FY25, though its revenue fell by 10% to ₹249 crore compared to ₹277 crore last year.

Oberoi Realty approved a plan to raise up to ₹6,000 crore through various financial instruments.

Zydus Lifesciences received US FDA approval to make a generic version of Paliperidone, a treatment for schizophrenia.

Earnings today: Companies expected to report quarterly earnings include Reliance Infrastructure, Just Dial, Hathway Cable, Jaypee Infratech, and more.